Rana Al Gahamdi

Dr. Rana Al Gahamdi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HNHouriah Y Nukaly
Houriah Y Nukaly
IHIbrahim Halawani
Ibrahim Halawani
SASaja Mohammed S. Alghamdi
Saja Mohammed S. Alghamdi
AAAraa Ghanem Alruwaili
Araa Ghanem Alruwaili
ABAlhanouf Khalid Binhezaim
Alhanouf Khalid Binhezaim
Abdulhadi JfriAbdulhadi Jfri
Abdulhadi Jfri
Background/Objectives: Oral Lichen Planus (OLP) is a common immune-mediated inflammatory disorder affecting the oral mucosa, impacting 0.5% to 2% of the global population, primarily middle-aged women. Immunological dysregulation is a key factor in OLP’s pathogenesis, involving CD4+ T helper and CD8+ T cytotoxic cells. The World Health Organization (WHO) classifies OLP as a potentially malignant disorder, with a risk of oral squamous cell carcinoma (OSCC) developing in up to 2% of lesions. This narrative review aims to provide a comprehensive overview of the etiopathogenesis, clinical manifestations, diagnostic criteria, and therapeutic strategies for OLP, informing clinical practice and guiding future research. Methods: A review of the literature from the PubMed and Google Scholar databases was conducted up to December 2023, focusing on studies addressing the etiopathogenesis, diagnosis, clinical manifestations, and treatment of OLP. Results: OLP’s pathogenesis is driven by immune dysregulation, with CD4+ and CD8+ cells playing crucial roles. Clinically, OLP presents as reticular, erosive, bullous, and plaque-like lesions. Diagnosis relies on clinical examination, histopathology, and direct immunofluorescence. Recent advancements in diagnostic markers and imaging techniques have improved detection and monitoring. Treatment primarily involves corticosteroids, but novel therapies such as curcumin, retinoids, and laser therapy are increasingly used for their effectiveness and reduced side effects. These treatments show promise in symptom reduction and recurrence prevention, although long-term data are needed. Conclusions: Regular screenings and biopsies are essential due to OLP’s likelihood of malignant transformation. This study urges further investigation into long-term results, improved diagnostic techniques, and evidence-based treatment regimens.

1 March 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
AJAzzam Zohair Jad
Azzam Zohair Jad
SASitah Mohammed Alotaibi
Sitah Mohammed Alotaibi
AAAmjad Asiri
Amjad Asiri
SAShouq Khalid Alobaid
Shouq Khalid Alobaid
RGRana Al Gahamdi
Rana Al Gahamdi
Abdullah AlmaqhawiAbdullah Almaqhawi
Abdullah Almaqhawi
Background: Missed primary care appointments disrupt continuity, reduce care quality, and increase healthcare costs. Despite numerous studies, global patterns and predictors of appointment non-adherence remain inconsistently reported. Objective: To identify, categorize, and evaluate the consistency of predictors of appointment non-adherence in primary care across diverse populations and healthcare systems. Methods: A systematic review was conducted following PRISMA guidelines (PROSPERO ID: CRD420251121963). PubMed/MEDLINE, Scopus, Web of Science, and Cochrane were searched in August 2025 for observational studies examining predictors of missed, canceled, or rescheduled primary care appointments. Study quality was appraised using the MINORS tool. Results: Twenty-seven observational studies (1982–2025) across eight countries were included, representing a total of more than 13 million appointments analyzed. Reported non-attendance varied widely (~5–31%). Predictors clustered into: patient-level (younger age, socioeconomic disadvantage, minority status in North American studies, mental health burden, and lower literacy/greater social needs), appointment-level (prior non-attendance and longer time between booking and visit), and clinic/system-level (access barriers such as transportation and scheduling friction). Telemedicine and continuity with the same clinician were associated with lower non-attendance in more recent studies. Due to heterogeneity in definitions and analyses, the results were synthesized narratively; overall study quality was modest–moderate by MINORS. Conclusions: Missed appointments reflect interacting patient- and system-level determinants, with the highest risk among younger and socioeconomically disadvantaged patients and those with mental health conditions. Interventions that reduce access friction (e.g., reminders, flexible scheduling/shorter lead times, transportation support) and equity-focused hybrid telemedicine may reduce non-adherence.

2 December 2025 in Health Science Reports
Verified
Journal Article
Open access
YKYasser Kofiah
Yasser Kofiah
TATurki Alkully
Turki Alkully
BBatol Albanghali
Batol Albanghali
HAHaya A. Alzahrani
Haya A. Alzahrani
SAShahad M. Alghamdi
Shahad M. Alghamdi
Mohammad A AlbanghaliMohammad A Albanghali
Mohammad A Albanghali
Background and Aim: Stroke remains one of the leading causes of long‐term disability worldwide, profoundly impacting patients' quality of life (QoL) and functional independence. This study aimed to assess quality of life (QoL) and functional outcomes among post‐stroke patients in Al‐Baha, Saudi Arabia, and to examine their associations with demographic, clinical, and rehabilitation factors. Methods: This study assessed QoL and functional outcomes among 125 post‐stroke patients in Al‐Baha, Saudi Arabia, from April 2023 to May 2024 at King Fahad Hospital. Quality of life (QoL) was evaluated using the EuroQol 5‐Dimension 3‐Level (EQ‐5D‐3L), while functional outcomes were measured with the Modified Rankin Scale (mRS). Associations of sociodemographic and clinical variables with QoL and functional outcomes were analyzed using chi‐square tests. Results: The mean QoL score was 14 ± 4.57, indicating moderate impairment. Mobility and pain/discomfort were the most impacted dimensions, with 12% and 37% of participants reporting extreme issues, respectively. Self‐rated health revealed that 45% of participants considered themselves ‘excellent’ health, while 19% rated their health as ‘poor’ ( p < 0.001). Younger participants (18–30 years) reported better QoL ( p = 0.025). Functional outcomes revealed that 59% had favorable mRS scores (0–2), while 41% had poor outcomes (3–6). Physiotherapy utilization was associated with functional outcomes, but poorer outcomes were observed among recipients likely due to selection bias. ( p = 0.047) but not with QoL scores. Conclusions: Findings highlight mobility limitations and pain/discomfort as the most affected dimensions of quality of life. Younger patients demonstrated better outcomes, while physiotherapy was associated with functional status, likely reflecting baseline severity rather than treatment effect. These results emphasize the importance of targeted, individualized rehabilitation strategies for post‐stroke populations.

30 June 2026 in International Journal of Retina and Vitreous
Verified
Journal Article
Open access
RARenad Alhomidi Almotiri
Renad Alhomidi Almotiri
ZAZahraa Hussain Alsaggaf
Zahraa Hussain Alsaggaf
YAYara Abosabaah
Yara Abosabaah
SASadeem Saad Abdulaziz Alkaluf
Sadeem Saad Abdulaziz Alkaluf
RGRana Al Gahamdi
Rana Al Gahamdi
SASarah Husam AlJefri
Sarah Husam AlJefri
Background: The rapid rise in intravitreal injections (IVIs) for vitreoretinal disorders underscores the need to optimize the procedure and support long-term patient compliance. Patient-reported pain and discomfort remain significant barriers to adherence. This systematic review evaluates the efficacy and safety of various local anesthetic methods for mitigating pain during IVIs. Methods: Conducted in accordance with PRISMA guidelines, a comprehensive search of PubMed and Google Scholar was performed to identify English-language randomized controlled trials (RCTs). Eligible studies included patients aged 18 years and older receiving local anesthesia for IVIs, where pain was quantified using standard visual or oral analog scales (0–10 or 0–100). Results: Our systematic review and meta-analysis included 14 RCTs comprising 1,300 patients. Analysis of topical lidocaine, tetracaine, and proparacaine formulations showed comparable analgesic efficacy, with all agents consistently achieving mild mean Visual Analog Scale (VAS) pain scores. No clinically meaningful superiority was identified among these primary agents ( p = 0.62). Adjunctive therapies, particularly physical cooling (e.g., ice patches), demonstrated significant pain-reducing potential. While oxybuprocaine alone was less effective, its combination with physical cooling achieved the lowest mean pain scores. Meanwhile, topical NSAIDs showed limited additional benefit. Regarding safety, subconjunctival anesthetic injections were associated with a significantly higher incidence of subconjunctival hemorrhage and chemosis compared to topical applications, suggesting that topical strategies provide a favorable safety and efficacy profile for routine intravitreal injections. Conclusion: In conclusion, this systematic review and meta-analysis confirms that no single topical anesthetic is superior for intravitreal injections; all primary agents provide comparable, effective pain control. Topical application is safer than subconjunctival injection, which is associated with higher rates of hemorrhage and chemosis. Consequently, clinical protocols should standardize low-risk topical methods and incorporate simple non-pharmacological adjuncts, such as physical cooling, to optimize patient comfort.